BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

121 related articles for article (PubMed ID: 25275065)

  • 1. Postoperative radiotherapy for gallbladder cancer.
    Jeong Y; Park JH; Lee YJ; Park KM; Hwang S; Chang HM; Kim KP; Yoon SM; Jung NH; Kim JH
    Anticancer Res; 2014 Oct; 34(10):5621-9. PubMed ID: 25275065
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Induction chemotherapy improved outcomes of patients with resectable esophageal cancer who received chemoradiotherapy followed by surgery.
    Jin J; Liao Z; Zhang Z; Ajani J; Swisher S; Chang JY; Jeter M; Guerrero T; Stevens CW; Vaporciyan A; Putnam J; Walsh G; Smythe R; Roth J; Yao J; Allen P; Cox JD; Komaki R
    Int J Radiat Oncol Biol Phys; 2004 Oct; 60(2):427-36. PubMed ID: 15380576
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Analysis of the efficacy of postoperative radiotherapy in gallbladder cancer].
    Yang L; Feng FL; Zhou HH; Sun YJ; Meng Y
    Zhonghua Zhong Liu Za Zhi; 2013 Jul; 35(7):534-9. PubMed ID: 24257308
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Prognostic factors in patients with gallbladder cancer after surgical resection: analysis of 279 operated patients.
    Lim H; Seo DW; Park DH; Lee SS; Lee SK; Kim MH; Hwang S
    J Clin Gastroenterol; 2013; 47(5):443-8. PubMed ID: 23188077
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Adjuvant therapy for gallbladder carcinoma: the Mayo Clinic Experience.
    Gold DG; Miller RC; Haddock MG; Gunderson LL; Quevedo F; Donohue JH; Bhatia S; Nagorney DM
    Int J Radiat Oncol Biol Phys; 2009 Sep; 75(1):150-5. PubMed ID: 19297105
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Role of adjuvant chemoradiotherapy for resected extrahepatic biliary tract cancer.
    Kim TH; Han SS; Park SJ; Lee WJ; Woo SM; Moon SH; Yoo T; Kim SS; Kim SH; Hong EK; Kim DY; Park JW
    Int J Radiat Oncol Biol Phys; 2011 Dec; 81(5):e853-9. PubMed ID: 21497455
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Treatment of gallbladder cancer by radical resection.
    Todoroki T; Kawamoto T; Takahashi H; Takada Y; Koike N; Otsuka M; Fukao K
    Br J Surg; 1999 May; 86(5):622-7. PubMed ID: 10361182
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Postoperative recurrent patterns of gallbladder cancer: possible implications for adjuvant therapy.
    Yuan Z; Shui Y; Liu L; Guo Y; Wei Q
    Radiat Oncol; 2022 Jul; 17(1):118. PubMed ID: 35799270
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The impact of resection margin status and postoperative CA19-9 levels on survival and patterns of recurrence after postoperative high-dose radiotherapy with 5-FU-based concurrent chemotherapy for resectable pancreatic cancer.
    Kinsella TJ; Seo Y; Willis J; Stellato TA; Siegel CT; Harpp D; Willson JK; Gibbons J; Sanabria JR; Hardacre JM; Schulak JP
    Am J Clin Oncol; 2008 Oct; 31(5):446-53. PubMed ID: 18838880
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Patterns of failure and prognostic factors for locoregional recurrence after radical surgery in upper urinary tract transitional cell carcinoma: implications for adjuvant radiotherapy.
    Jang NY; Kim IA; Byun SS; Lee SE; Kim JS
    Urol Int; 2013; 90(2):202-6. PubMed ID: 23257513
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Surgical management for carcinoma of the gallbladder: a single-institution experience in 25 years.
    Liang JW; Dong SX; Zhou ZX; Tian YT; Zhao DB; Wang CF; Zhao P
    Chin Med J (Engl); 2008 Oct; 121(19):1900-5. PubMed ID: 19080121
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Evaluation of surgical resection for gallbladder carcinoma at a Japanese cancer institute.
    Nanashima A; Tobinaga S; Abo T; Morisaki T; Uehara R; Takeshita H; Nonaka T; Hidaka S; Takeshima F; Ohnita K; Isomoto H; Kunizaki M; Sawai T; Nakao K; Nagayasu T
    Hepatogastroenterology; 2012 Sep; 59(118):1717-21. PubMed ID: 22819898
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Extended operation with or without intraoperative (IORT) and external (EBRT) radiotherapy for gallbladder carcinoma.
    Lindell G; Holmin T; Ewers SB; Tranberg KG; Stenram U; Ihse I
    Hepatogastroenterology; 2003; 50(50):310-4. PubMed ID: 12749210
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Treatment outcome for synchronous locoregional failures of nasopharyngeal carcinoma.
    Chua DT; Wei WI; Sham JS; Cheng AC; Au G
    Head Neck; 2003 Jul; 25(7):585-94. PubMed ID: 12808662
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Comparison of outcomes for patients with medically inoperable Stage I non-small-cell lung cancer treated with two-dimensional vs. three-dimensional radiotherapy.
    Fang LC; Komaki R; Allen P; Guerrero T; Mohan R; Cox JD
    Int J Radiat Oncol Biol Phys; 2006 Sep; 66(1):108-16. PubMed ID: 16904517
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Benefits of combining radiotherapy with aggressive resection for stage IV gallbladder cancer.
    Todoroki T; Kawamoto T; Otsuka M; Koike N; Yoshida S; Takada Y; Adachi S; Kashiwagi H; Fukao K; Ohara K
    Hepatogastroenterology; 1999; 46(27):1585-91. PubMed ID: 10430299
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Prognostic factors in patients with advanced hypopharyngeal squamous cell carcinoma treated with concurrent chemoradiotherapy.
    Krstevska V; Stojkovski I; Zafirova-Ivanovska B; Crvenkova S
    J BUON; 2012; 17(2):327-36. PubMed ID: 22740214
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Adjuvant therapy for gallbladder and bile duct cancers: retrospective comparative study.
    Tugba Kos F; Aksoy S; Odabas H; Ozdemir N; Oksuzoglu B; Uncu D; Zengin N
    J BUON; 2011; 16(3):464-8. PubMed ID: 22006751
    [TBL] [Abstract][Full Text] [Related]  

  • 19. External-beam radiotherapy for localized extrahepatic cholangiocarcinoma.
    Ben-David MA; Griffith KA; Abu-Isa E; Lawrence TS; Knol J; Zalupski M; Ben-Josef E
    Int J Radiat Oncol Biol Phys; 2006 Nov; 66(3):772-9. PubMed ID: 17011452
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Carcinoma of the gallbladder: patterns of presentation, prognostic factors and survival rate. An 11-year single centre experience.
    D'Hondt M; Lapointe R; Benamira Z; Pottel H; Plasse M; Letourneau R; Roy A; Dagenais M; Vandenbroucke-Menu F
    Eur J Surg Oncol; 2013 Jun; 39(6):548-53. PubMed ID: 23522952
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.